Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Phreesia, Inc.PHR · Entity 2606 | Director | June 24, 2026 | June 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Phreesia, Inc.
Report date June 24, 2026 · Filed June 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 43,884 |
Reported balance
After 2026-06-24 transaction · row 1
1 source rowRow 1 · 2026-06-24 · Grant · Acquired 19,290 · Balance 43,884 F1: The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in full upon the earlier of (i) June 24, 2027 and (ii) the next annual meeting of the Issuer's stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in full upon the earlier of (i) June 24, 2027 and (ii) the next annual meeting of the Issuer's stockholders.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
HEALTHEQUITY, INC.
Report date June 06, 2025 · Filed June 10, 2025
Section 16 reporting ended · disclosed 2025-06-10. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 253,510 |
Ending reported balance
After 2025-06-06 transaction · row 7
7 source rows · reconciled sequenceRow 1 · 2025-06-06 · Exercise / conversion · Acquired 17,409 · Balance 325,421 Row 2 · 2025-06-06 · Exercise / conversion · Acquired 23,929 · Balance 349,350 Row 3 · 2025-06-06 · Exercise / conversion · Acquired 38,343 · Balance 387,693 Row 4 · 2025-06-06 · Sale · Disposed 62,827 · Balance 324,866 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.25 to $112.24, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 2, 3, 4, 6, 7 and 8 of this Form 4. Row 5 · 2025-06-06 · Sale · Disposed 16,854 · Balance 308,012 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.27 to $112.63, inclusive. Row 6 · 2025-06-06 · Sale · Disposed 39,075 · Balance 268,937 F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $111.43 to $112.42, inclusive Row 7 · 2025-06-06 · Sale · Disposed 15,427 · Balance 253,510 F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $112.43 to $113.35, inclusive. |
| Common StockSEC Table I · non-derivative | Indirectby GKF, LLC | 136,055 |
Reported balance
After 2025-06-06 transaction · row 8
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 8 · 2025-06-06 · Exercise / conversion · Acquired 34,820 · Balance 136,055 F5: These securities are held by GKF, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| Common StockSEC Table I · non-derivative | Indirectby GKF, LLC | 159,985 |
Reported balance
After 2025-06-06 transaction · row 9
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 9 · 2025-06-06 · Exercise / conversion · Acquired 23,930 · Balance 159,985 F5: These securities are held by GKF, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| Common StockSEC Table I · non-derivative | Indirectby GKF, LLC | 172,767 |
Reported balance
After 2025-06-06 transaction · row 10
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 10 · 2025-06-06 · Exercise / conversion · Acquired 12,782 · Balance 172,767 F5: These securities are held by GKF, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| Common StockSEC Table I · non-derivative | Indirectby GKF, LLC | 120,317 |
Reported balance
After 2025-06-06 transaction · row 11
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 11 · 2025-06-06 · Sale · Disposed 52,450 · Balance 120,317 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.25 to $112.24, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 2, 3, 4, 6, 7 and 8 of this Form 4. F5: These securities are held by GKF, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| Common StockSEC Table I · non-derivative | Indirectby GKF, LLC | 101,235 |
Reported balance
After 2025-06-06 transaction · row 12
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 12 · 2025-06-06 · Sale · Disposed 19,082 · Balance 101,235 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.27 to $112.63, inclusive. F5: These securities are held by GKF, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| Common StockSEC Table I · non-derivative | Indirectby GKF, LLC | 84,688 |
Reported balance
After 2025-06-06 transaction · row 13
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 13 · 2025-06-06 · Sale · Disposed 16,547 · Balance 84,688 F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $111.34 to $112.33, inclusive. |
| Common StockSEC Table I · non-derivative | Indirectby GKF, LLC | 75,060 |
Reported balance
After 2025-06-06 transaction · row 14
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 14 · 2025-06-06 · Sale · Disposed 9,628 · Balance 75,060 F7: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $112.34 to $113.33, inclusive. |
| Common StockSEC Table I · non-derivative | Indirectby GKF, LLC | 75,000 |
Reported balance
After 2025-06-06 transaction · row 15
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 15 · 2025-06-06 · Sale · Disposed 60 · Balance 75,000 F8: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $113.34 to $113.36, inclusive. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $41.28 · Expires 2027-03-27 | Direct | 0 |
Reported balance
After 2025-06-06 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2025-06-06 · Exercise / conversion · Disposed 17,409 · Balance 0 F9: The option is immediately exercisable. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $61.72 · Expires 2028-03-27 | Direct | 0 |
Reported balance
After 2025-06-06 transaction · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · 2025-06-06 · Exercise / conversion · Disposed 23,929 · Balance 0 F9: The option is immediately exercisable. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $73.61 · Expires 2029-03-26 | Direct | 0 |
Reported balance
After 2025-06-06 transaction · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · 2025-06-06 · Exercise / conversion · Disposed 38,343 · Balance 0 F9: The option is immediately exercisable. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $41.28 · Expires 2027-03-27 | Indirectby GKF, LLC | 0 |
Reported balance
After 2025-06-06 transaction · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · 2025-06-06 · Exercise / conversion · Disposed 34,820 · Balance 0 F9: The option is immediately exercisable. F5: These securities are held by GKF, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $61.72 · Expires 2028-03-27 | Indirectby GKF, LLC | 0 |
Reported balance
After 2025-06-06 transaction · row 20
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 20 · 2025-06-06 · Exercise / conversion · Disposed 23,930 · Balance 0 F9: The option is immediately exercisable. F5: These securities are held by GKF, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $73.61 · Expires 2029-03-26 | Indirectby GKF, LLC | 0 |
Reported balance
After 2025-06-06 transaction · row 21
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 21 · 2025-06-06 · Exercise / conversion · Disposed 12,782 · Balance 0 F9: The option is immediately exercisable. F5: These securities are held by GKF, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.25 to $112.24, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 2, 3, 4, 6, 7 and 8 of this Form 4.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.27 to $112.63, inclusive.
F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $111.43 to $112.42, inclusive
F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $112.43 to $113.35, inclusive.
F5: These securities are held by GKF, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $111.34 to $112.33, inclusive.
F7: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $112.34 to $113.33, inclusive.
F8: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $113.34 to $113.36, inclusive.
F9: The option is immediately exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 12, 2019 Filed Jul 15, 2019 20:50 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | PurchaseCommon Stock | 10,000 | $61.00 | $610,000.00 |
DisclosureSEC source: 0001179110-19-008645 · edgar.xml · nonDerivative · entry 1 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 442,410 Read SEC document |
| March 26, 2019 Filed Mar 28, 2019 21:24 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantStock Option (right to buy) · Derivative | 160,000 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001179110-19-004371 · edgar.xml · derivative · entry 5 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Underlying: Common Stock · 160,000 shares Expires 2024-07-30 F4 · shares: On July 30, 2014, the reporting person was granted an option to purchase 400,000 shares of common stock. The option vests in annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending January 31, 2016 (10%), 2017 (20%), 2018 (30%) and 2019 (40%). The performance criteria for 2019 were met, resulting in the vesting of the option as to 160,000 shares. F5 · derivative.exercise_date: The option is immediately exercisable Read SEC document |
| March 26, 2019 Filed Mar 28, 2019 21:24 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantStock Option (right to buy) · Derivative | 51,125 | $0.00 Strike: $73.61 | $0.00 |
DisclosureSEC source: 0001179110-19-004371 · edgar.xml · derivative · entry 4 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,125 Underlying: Common Stock · 51,125 shares Expires 2029-03-26 F3 · derivative.exercise_date: The option will vest as to 12,782 shares on March 26, 2020. The remaining options will vest in annual installments of 12,781 on each of March 26, 2021, 2022 and 2023. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 22:29 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 17,410 | $0.00 Strike: $41.28 | $0.00 |
DisclosureSEC source: 0001179110-18-014071 · edgar.xml · derivative · entry 2 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,229 Underlying: Common Stock · 17,410 shares Expires 2027-03-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option became exercisable as to 17,410 shares on March 27, 2018. The remaining options will become exercisable in two annual installments of 17,410 shares on March 27, 2019 and 2020. The option becomes exercisable as to the remaining 17, 409 shares on March 27, 2021. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 22:29 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 17,410 | $41.28 | $718,684.80 |
DisclosureSEC source: 0001179110-18-014071 · edgar.xml · nonDerivative · entry 1 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 432,410 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2018 Filed May 4, 2018 21:08 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006324 · edgar.xml · derivative · entry 4 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 120,000 shares Expires 2024-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2017. F3 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| May 02, 2018 Filed May 4, 2018 21:08 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 120,000 | $66.83 | $8,019,672.00 |
DisclosureSEC source: 0001179110-18-006324 · edgar.xml · nonDerivative · entry 2 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 415,000 F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2017. Read SEC document |
| May 02, 2018 Filed May 4, 2018 21:08 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 120,000 | $14.00 | $1,680,000.00 |
DisclosureSEC source: 0001179110-18-006324 · edgar.xml · nonDerivative · entry 1 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 535,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2017. Read SEC document |
| March 27, 2018 Filed Mar 29, 2018 20:26 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantStock Option (right to buy) · Derivative | 47,859 | $0.00 Strike: $61.72 | $0.00 |
DisclosureSEC source: 0001179110-18-004914 · edgar.xml · derivative · entry 4 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,859 Underlying: Common Stock · 47,859 shares Expires 2028-03-27 F4 · derivative.exercise_date: The option becomes exercisable in three equal installments of 11,965 shares on March 27, 2019, 2020, and 2021. The option becomes exercisable as to the remaining 11,964 shares on March 27, 2022. Read SEC document |
| March 27, 2018 Filed Mar 29, 2018 20:26 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantStock Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001179110-18-004914 · edgar.xml · derivative · entry 3 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2024-07-30 F2 · shares: On June 30, 2014, the reporting person was granted an option to purchase 400,000 shares of common stock. The option vests in annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending January 31, 2016 (10%), 2017 (20%), 2018 (30%) and 2019 (40%). The performance criteria for 2018 were met, resulting in the vesting of the option as to 120,000 shares. F3 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| March 23, 2018 Filed Mar 29, 2018 20:26 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GiftCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-004914 · edgar.xml · nonDerivative · entry 1 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 415,000 Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 22:22 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 59,558 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001179110-18-002597 · edgar.xml · derivative · entry 4 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 59,558 shares Expires 2024-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2017. F4 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 22:22 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 800 | $56.04 | $44,832.00 |
DisclosureSEC source: 0001179110-18-002597 · edgar.xml · nonDerivative · entry 3 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 445,000 F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2017. F3 · price: These shares were sold in a single transaction at a price of $56.04 per share. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 22:22 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 58,758 | $55.31 | $3,250,145.89 |
DisclosureSEC source: 0001179110-18-002597 · edgar.xml · nonDerivative · entry 2 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 445,800 F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.93, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 22:22 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 59,558 | $14.00 | $833,812.00 |
DisclosureSEC source: 0001179110-18-002597 · edgar.xml · nonDerivative · entry 1 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 504,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2017. Read SEC document |
| February 16, 2018 Filed Feb 17, 2018 00:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 2,775 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001179110-18-002332 · edgar.xml · derivative · entry 9 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,558 Underlying: Common Stock · 2,775 shares Expires 2024-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2017. F5 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| February 16, 2018 Filed Feb 17, 2018 00:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 2,775 | $55.01 | $152,651.92 |
DisclosureSEC source: 0001179110-18-002332 · edgar.xml · nonDerivative · entry 6 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 445,000 F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2017. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.09, inclusive. Read SEC document |
| February 16, 2018 Filed Feb 17, 2018 00:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 2,775 | $14.00 | $38,850.00 |
DisclosureSEC source: 0001179110-18-002332 · edgar.xml · nonDerivative · entry 5 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 447,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2017. Read SEC document |
| February 15, 2018 Filed Feb 17, 2018 00:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Options (right to buy) · Derivative | 16,335 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001179110-18-002332 · edgar.xml · derivative · entry 8 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,333 Underlying: Common Stock · 16,335 shares Expires 2024-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2017. F5 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| February 15, 2018 Filed Feb 17, 2018 00:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 16,335 | $55.02 | $898,779.47 |
DisclosureSEC source: 0001179110-18-002332 · edgar.xml · nonDerivative · entry 4 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 445,000 F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2017. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.16, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (4) to this Form 4. Read SEC document |
| February 15, 2018 Filed Feb 17, 2018 00:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 16,335 | $14.00 | $228,690.00 |
DisclosureSEC source: 0001179110-18-002332 · edgar.xml · nonDerivative · entry 3 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 461,335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2017. Read SEC document |
| February 14, 2018 Filed Feb 17, 2018 00:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 1,332 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001179110-18-002332 · edgar.xml · derivative · entry 7 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,668 Underlying: Common Stock · 1,332 shares Expires 2024-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2017. F5 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| February 14, 2018 Filed Feb 17, 2018 00:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 1,332 | $55.00 | $73,260.00 |
DisclosureSEC source: 0001179110-18-002332 · edgar.xml · nonDerivative · entry 2 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 445,000 F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2017. F2 · price: These shares were sold in a single transaction at $55.00 per share. Read SEC document |
| February 14, 2018 Filed Feb 17, 2018 00:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 1,332 | $14.00 | $18,648.00 |
DisclosureSEC source: 0001179110-18-002332 · edgar.xml · nonDerivative · entry 1 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 446,332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2017. Read SEC document |
| January 25, 2018 Filed Jan 29, 2018 22:42 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001179110-18-001187 · edgar.xml · derivative · entry 4 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 40,000 shares Expires 2024-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2017. F4 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| January 25, 2018 Filed Jan 29, 2018 22:42 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 8,761 | $50.10 | $438,936.61 |
DisclosureSEC source: 0001179110-18-001187 · edgar.xml · nonDerivative · entry 3 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 445,000 F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2017. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.92 to $50.35, inclusive. Read SEC document |
| January 25, 2018 Filed Jan 29, 2018 22:42 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 31,239 | $49.29 | $1,539,754.69 |
DisclosureSEC source: 0001179110-18-001187 · edgar.xml · nonDerivative · entry 2 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 453,761 F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.87 to $49.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| January 25, 2018 Filed Jan 29, 2018 22:42 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 40,000 | $14.00 | $560,000.00 |
DisclosureSEC source: 0001179110-18-001187 · edgar.xml · nonDerivative · entry 1 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 485,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2017. Read SEC document |
| September 01, 2017 Filed Sep 1, 2017 19:17 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001140361-17-034126 · doc1.xml · derivative · entry 2 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2021-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| September 01, 2017 Filed Sep 1, 2017 19:17 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 25,000 | $1.25 | $31,250.00 |
DisclosureSEC source: 0001140361-17-034126 · doc1.xml · nonDerivative · entry 1 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 445,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2017 Filed Jun 10, 2017 01:12 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001140361-17-024622 · doc1.xml · derivative · entry 3 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 150,000 shares Expires 2021-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016. F3 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| June 07, 2017 Filed Jun 10, 2017 01:12 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 150,000 | $50.27 | $7,541,070.00 |
DisclosureSEC source: 0001140361-17-024622 · doc1.xml · nonDerivative · entry 2 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420,000 F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.95 to $50.93, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| June 07, 2017 Filed Jun 10, 2017 01:12 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 150,000 | $1.25 | $187,500.00 |
DisclosureSEC source: 0001140361-17-024622 · doc1.xml · nonDerivative · entry 1 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 570,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016. Read SEC document |
| June 01, 2017 Filed Jun 6, 2017 00:15 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001140361-17-023861 · doc1.xml · derivative · entry 5 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 30,000 shares Expires 2021-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016. F5 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| June 01, 2017 Filed Jun 6, 2017 00:15 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 7,529 | $47.51 | $357,697.52 |
DisclosureSEC source: 0001140361-17-023861 · doc1.xml · nonDerivative · entry 4 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420,000 F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.36 to $47.95, inclusive. Read SEC document |
| June 01, 2017 Filed Jun 6, 2017 00:15 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 10,481 | $47.05 | $493,081.79 |
DisclosureSEC source: 0001140361-17-023861 · doc1.xml · nonDerivative · entry 3 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 427,529 F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.36 to $47.35, inclusive. Read SEC document |
| June 01, 2017 Filed Jun 6, 2017 00:15 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 11,990 | $45.44 | $544,878.36 |
DisclosureSEC source: 0001140361-17-023861 · doc1.xml · nonDerivative · entry 2 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 438,010 F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.33 to $46.29, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. Read SEC document |
| June 01, 2017 Filed Jun 6, 2017 00:15 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 30,000 | $1.25 | $37,500.00 |
DisclosureSEC source: 0001140361-17-023861 · doc1.xml · nonDerivative · entry 1 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016. Read SEC document |
| May 01, 2017 Filed May 3, 2017 01:10 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001140361-17-017978 · doc1.xml · derivative · entry 4 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,000 Underlying: Common Stock · 30,000 shares Expires 2021-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016. F4 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| May 01, 2017 Filed May 3, 2017 01:10 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 4,900 | $46.13 | $226,057.58 |
DisclosureSEC source: 0001140361-17-017978 · doc1.xml · nonDerivative · entry 3 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420,000 F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.99 to $46.31, inclusive. Read SEC document |
| May 01, 2017 Filed May 3, 2017 01:10 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 25,100 | $45.29 | $1,136,819.16 |
DisclosureSEC source: 0001140361-17-017978 · doc1.xml · nonDerivative · entry 2 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,900 F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.99 to $45.98, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| May 01, 2017 Filed May 3, 2017 01:10 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 30,000 | $1.25 | $37,500.00 |
DisclosureSEC source: 0001140361-17-017978 · doc1.xml · nonDerivative · entry 1 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016. Read SEC document |
| April 04, 2017 Filed Apr 5, 2017 23:01 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001140361-17-015040 · doc1.xml · derivative · entry 6 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,000 Underlying: Common Stock · 10,000 shares Expires 2021-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016. F4 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| April 04, 2017 Filed Apr 5, 2017 23:01 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 10,000 | $43.01 | $430,104.00 |
DisclosureSEC source: 0001140361-17-015040 · doc1.xml · nonDerivative · entry 4 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420,000 F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.95 to $43.14, inclusive. Read SEC document |
| April 04, 2017 Filed Apr 5, 2017 23:01 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 10,000 | $1.25 | $12,500.00 |
DisclosureSEC source: 0001140361-17-015040 · doc1.xml · nonDerivative · entry 3 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 430,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 23:01 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001140361-17-015040 · doc1.xml · derivative · entry 5 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,000 Underlying: Common Stock · 20,000 shares Expires 2021-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016. F4 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 23:01 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 20,000 | $41.85 | $837,068.00 |
DisclosureSEC source: 0001140361-17-015040 · doc1.xml · nonDerivative · entry 2 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420,000 F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.52 to $42.43, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 23:01 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 20,000 | $1.25 | $25,000.00 |
DisclosureSEC source: 0001140361-17-015040 · doc1.xml · nonDerivative · entry 1 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 440,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2016. Read SEC document |
| March 27, 2017 Filed Mar 30, 2017 01:06 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantStock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001140361-17-013836 · doc1.xml · derivative · entry 3 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 80,000 shares Expires 2024-07-30 F2 · shares: On June 30, 2014, the reporting person was granted an option to purchase 400,000 shares of common stock. The option vests in annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending January 31, 2016 (10%), 2017 (20%), 2018 (30%) and 2019 (40%). The performance criteria for 2017 were met, resulting in the vesting of the option as to 80,000 shares. F3 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| March 27, 2017 Filed Mar 30, 2017 01:06 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantStock Option (right to buy) · Derivative | 69,639 | $0.00 Strike: $41.28 | $0.00 |
DisclosureSEC source: 0001140361-17-013836 · doc1.xml · derivative · entry 2 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,639 Underlying: Common Stock · 69,639 shares Expires 2027-03-27 F1 · derivative.exercise_date: The option becomes exercisable as to 17,409 shares on March 27, 2018 and in three annual installments of 17,410 shares on March 27, 2019, 2020 and 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.